Leveraging of CDISC Standards to Support Dissemination, Integration and Analysis of Raw Clinical Trials Data to Advance Open Science

Size: px
Start display at page:

Download "Leveraging of CDISC Standards to Support Dissemination, Integration and Analysis of Raw Clinical Trials Data to Advance Open Science"

Transcription

1 Leveraging of CDISC Standards to Support Dissemination, Integration and Analysis of Raw Clinical Trials Data to Advance Open Science Ravi Shankar Research Scientist, Division of Systems Medicine, Stanford University Member, NIAID ImmPort 1

2 Open access to clinical trials data advances open science Broad open access to entire clinical trial data is on the rise Tremendous opportunity to evaluate new hypotheses that were not originally formulated in the studies by performing cross analysis of clinical trials by combining with other open biomedical datasets We are developing standards-based methodologies for uniformly representing clinical trial data to support dissemination, integration and analysis.

3 Industry and Government Opening the Clinical Trial Data Vault

4 immport.niaid.nih.gov

5 ImmPort redistributes data from major NIAID-funded programs Data from 60+ trials already released, involving: Collaborative Network for Clinical Research on Immune Tolerance Network Atopic Dermatitis Research Network (ADRN) Clinical Trials in Organ Transplantation (CTOT) Clinical Trials in Organ Transplantation in Children (CTOT-C) Population Genetics Analysis Program Protective Immunity for Special Populations HLA Region Genomics in Immune-mediated Diseases Maintenance of Macaque Specific Pathogen-Free Breeding Colonies Modeling Immunity for Biodefense Reagent Development for Toll-like and other Innate Immune Receptors Adjuvant Development Program Innate Immune Receptors and Adjuvant Discovery Program Human Immunology Project Consortium Non-human Primate Transplantation Tolerance Cooperative Study Group

6 Open Biomedical Datasets 5,178 compounds 1,300 off-patent FDA-approved drugs 700 bioactive tool compounds 2,000+ screening hits (MLPCN and others) 3,712 genes (shrna + cdna) targets/pathways of FDA-approved drugs (n=900) candidate disease genes (n=600) community nominations (n=500+) 15 cell types Banked primary cell types Cancer cell lines Primary htert immortalized Patient derived ips cells 5 community nominated

7 New Open Science by Integrating Open Clinical Trial Data with Biomedical Datasets Looking at data is good; reanalyzing it is great Clinical trial results can be reproduced and expanded Discover new markers for personalized medicine While individual studies are great, pooling studies may be more powerful Pooling experimental results enables new questions Let s learn why trials work and fail Linking open biomedical and clinical trial data will enable even more virtual studies and findings

8 Clinical Trial Data To support the integration and analysis of clinical trials data We are creating uniform representations of clinical trial data. We are enabling easy access to uniformly represented clinical trial data in analytical environments. represent Uniformly Represented Clinical Trial Data export bridge Open Clinical Trial Repositories Dissemination Analytical Environments (R, SAS) Analysis

9 The 5 Major Steps from Raw Data to to Publish to Ready-for-analysis 1. Scope the clinical trial data types that we want to include for dissemination purposes. 2. Define a set of clinical trial domain entities (an ontology) required to uniformly represent the clinical trial data. 3. Using the ontology, encode specific clinical trial data to create uniformly represented data. 4. Publish the encoded clinical trial data. 5. Create bridges between the encoded data and analytical environments to provide easy access to data for analysis.

10 Towards Minimum Information About Clinical Trial for Dissemination Study Summary Study Objectives and Outcome Measures Study Design Schedule of Activities Study Subjects Clinical Data Experimental Data Adverse Events Analysis Data

11 Building a Standards-Based Clinical Trial Ontology a Formal Description of the Clinical Trial Domain Leverage of data elements defined in CDISC Standards e.g. Study, Arm, Study Subject Link with appropriate reference biomedical ontologies Clinical Trial Ontology (CTO) PRM TDM CDASH SDTM Data Dissemination Elements ODM ADaM SEND BRIDG NCI Thesaurus SNOMED CT Use Upper-level, Structural and Domain Ontologies BFO RDF Data Cube GO NDF-RT BAO PRO CL IAO OGMS 11

12 Using Semantic web standards to represent and disseminate clinical trial data Semantic web standards allow data to be shared and reused over the web OWL Web Ontology Language SPARQL RDF Query Language RDF Resource Description Framework URI Uniform Resource Identifier

13 Describing the Clinical Trial Domain as a Set of OWL Axioms Descriptions of a clinical trial entity such as its parent entity, its relationships with other entities and value restrictions are formally expressed as logical axioms to create the Clinical Trial Ontology InterventionalStudy is a subtype of Study Study has title that is of type string arm relates Arm to a Study Study Subject is a subtype of Person with role as Subject Role

14 Exploring RDF Data Cube for representing and analyzing multi-dimensional longitudinal data CUBE - a set of observations indexed by dimensions (e.g., arms, months after transplant ) describing measures (e.g., standard height) interpreted according to attributes (e.g., z-score) OBSERVATION measured values (with attributes) at dimensions SLICE optional grouping of observations by fixing dimensions

15 Exploring RDF Data Cube for representing and analyzing multi-dimensional longitudinal data CUBE - a set of observations indexed by dimensions (e.g., arms, months after transplant ) describing measures (e.g., standard height) interpreted according to attributes (e.g., z-score) OBSERVATION measured values (with attributes) at dimensions SLICE optional grouping of observations by fixing dimensions

16 Identifying Data Elements using URI Each clinical trial data element is assigned a unique identifier, a URI Study: CCTPT_SW01 URI - Planned Activity: Medical History URI - Study Subject: Subject 10 URI -

17 Representing Clinical Trial Data as a Collection of RDF Triples In RDF, data is represented as triples predicate Subject Object arm1 Using the entities in the CTO ontology (Study, title, arm, Planned Activity, etc.), the entire CCTPT_SW01 data can be represented as a collection of RDF triples CCTPT_SW01 type of type of Arm Study CCTPT_SW01 CCTPT_SW01 arm title arm1 A double-blind randomized trial of steroid withdrawal label... arm1 Steroid withdrawal arm

18 Linked Clinical Trial Data The collection of RDF triples can be viewed as linked data And, can be linked to external data sets Study type of arm title CCTPT_SW01 A double-blind randomized trial of steroid withdrawal type of Arm arm1 label Steroid withdrawal arm NCI Thesaurus

19 Biomedical Research Data Moving Towards RDF

20 Open Clinical Trial Data can be part of the Open Linked Data Cloud CCTPT-SW01 Clinical Trial Data in RDF

21 RDF Encoding of Clinical Trials Data using a Standards-based Clinical Trial Ontology Clinical Trial Data Clinical Trial Ontology (OWL) represent OWL / RDF Editor Encoded Clinical Trials (RDF) CDISC Standards, Other Ontologies & Linked Data export bridge Open Clinical Trial Repositories Dissemination Analytical Environments (R, SAS) Analysis

22 Accessing RDF Encoded Clinical Trials Data as R Data Objects a protoype Clinical Trial Data Clinical Trial Ontology (OWL) represent OWL / RDF Editor Encoded Clinical Trials (RDF) CDISC Standards, Other Ontologies & Linked Data export Jena RDF API bridge rrdf Open Clinical Trial Repositories Dissemination Clinical Trial Data Objects in R Analysis

23 Loading the RDF Encoded Clinical Trial Data in R a prototype bridge Create R data classes that correspond to the Clinical Trial Ontology (CTO) entities. CTO Entities Study title (string) R Classes Study <- setrefclass("study", fields = list(title = "character )) Query the RDF triples and populate the R classes with clinical trial data. Using R RDF libraries for SPARQL queries

24 > cctpt_sw01 = loadstudy(<clinical Trial URI>) A single line of R code can load the entire clinical trial data into R for analysis > cctpt_sw01 = loadstudy(" > cctpt_sw01$title title "A DOUBLE-BLIND RANDOMIZED TRIAL OF STEROID WITHDRAWAL IN SIROLIMUS- AND CYCLOSPORINE-TREATED PRIMARY TRANSPLANT RECIPIENTS" > cctpt_sw01$arms [[1]] Reference class object of class "Arm" Field "name": name "Control arm" [[2]] Reference class object of class "Arm" Field "name": name "Steroid withdrawal arm"

25 Summary We are using semantic web standards to create the clinical trial ontology (CTO) and to uniformly represent and disseminate clinical trial data. Our work in scoping the clinical trial ontology space can be a step towards a standard for minimum information about a clinical trial. We are developing bridges between encoded clinical trial data and analytical environments to enable easy access to clinical trial data. We are enabling pooling of clinical trials data and integration with other biomedical datasets to advance open science. 25

26 Acknowledgements NIAID ImmPort at Northrop Grumman (Jeff Wiser and team) Stanford University (Atul Butte and team) University of Buffalo (Barry Smith and team) Funding: NIAID Bioinformatics Integration Support Contract (BISC) HSN C Initiating discussions with the CDISC community 26

CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource

CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource CDISC/TransCelerate Collaboration and TransCelerate work streams -Clinical Data Standards -Common Protocol Template -esource July 2016 TransCelerate Clinical Data Standards Project Opportunity

More information

Industrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence

Industrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Industrialized Clinical Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Executive Summary The majority of commercially available legacy

More information

Janus Clinical Trials Repository: Modernizing the Review Process through Innovation

Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration Janus Clinical Trials Repository

More information

Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition

Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition David Izard, MS Terek Peterson, MBA Richard Addy, MS CDISC ODM SDTM LAB CDASH ADaM PRM SEND Controlled

More information

CDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008

CDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008 CDISC Controlled Terminology across the Clinical Trial Continuum Bay Area Implementation Network 6 March 2008 Bron Kisler Co-Founder / Director of Terminology CDISC Terminology Initiative Overview / Background

More information

October, Integration and Implementation of CDISC Standards

October, Integration and Implementation of CDISC Standards Integration and Implementation of CDISC Standards October, 2008 Barbara Lentz, Associate Director, Electronic Data Management Standards, Processes & Training Pat Majcher, Statistical Reporting Services

More information

CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017

CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC Tech Webinar Leveraging CDISC Standards to Drive Crosstrial Analytics; Graph Technology and A3 Informatics 26 OCT 2017 CDISC 2017 1 Panelists Jim LaPointe Managing Director, Cambridge Semantics Patrick

More information

From Standards that Cost to Standards that Save: Cost Effective Standards Implementation

From Standards that Cost to Standards that Save: Cost Effective Standards Implementation From Standards that Cost to Standards that Save: Cost Effective Standards Implementation Jeffrey M. Abolafia, Rho, Chapel Hill, NC Frank DiIorio, CodeCrafters Inc., Philadelphia, PA Warning This presentation

More information

CDISC Standards: Current and Future

CDISC Standards: Current and Future CDISC 2010 CDISC Standards: Current and Future CDISC Japan Interchange Tokyo, Japan 20 July 2010 Rebecca D. Kush, PhD President and CEO, CDISC Clinical Research Standards (Content) (Protocol-driven Research;

More information

CDISC UK Network face to face Reading

CDISC UK Network face to face Reading CDISC UK Network face to face Reading Paul Houston, CDISC Head of European Operations CDISC Update and European Activity 2 CDISC Values and Principals Core value Foster CDISC community is altruistic

More information

CDASH Clinical Data Acquisition Standards Harmonization

CDASH Clinical Data Acquisition Standards Harmonization CDISC Italian User Group Meeting 16 November 2007 CDASH Clinical Data Acquisition Standards Harmonization 1 Outline Background Organization Goals Timelinesand Process Review of progress Results Future

More information

Disease Compass A Navigation System for Disease Knowledge based on Ontology and Linked Data Techniques

Disease Compass A Navigation System for Disease Knowledge based on Ontology and Linked Data Techniques Disease Compass A Navigation System for Disease Knowledge based on Ontology and Linked Data Techniques Kouji Kozaki,*, Yuki Yamagata, Riichiro Mizoguchi,*, Takeshi Imai and Kazuhiko Ohe ISIR, Osaka University,

More information

End-to-End Management of Clinical Trials Data

End-to-End Management of Clinical Trials Data End-to-End Management of Clinical Trials Data A Revolutionary Step Toward Supporting Clinical Trials Analysis Over the Next Decades of Clinical Research WHITE PAPER SAS White Paper Table of Contents Introduction....

More information

What is Genetic Engineering?

What is Genetic Engineering? Selective Breeding Selective Breeding is when someone (humans) breed organisms with specific traits in order to produce offspring having those same traits. This is also called artificial selection, the

More information

QIAN ZHU. Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA CUI TAO

QIAN ZHU. Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA   CUI TAO EXPLORING THE PHARMACOGENOMICS KNOWLEDGE BASE (PHARMGKB) FOR REPOSITIONING BREAST CANCER DRUGS BY LEVERAGING WEB ONTOLOGY LANGUAGE (OWL) AND CHEMINFORMATICS APPROACHES * QIAN ZHU Department of Health Sciences

More information

PharmaSUG Paper PO12

PharmaSUG Paper PO12 PharmaSUG 2016 - Paper PO12 CDISC Standards End-to-End: Transitional Hurdles Alyssa Wittle, Chiltern International, King of Prussia, PA Christine McNichol, Chiltern International, King of Prussia, PA Antonio

More information

20.453J / 2.771J / HST.958J Biomedical Information Technology

20.453J / 2.771J / HST.958J Biomedical Information Technology MIT OpenCourseWare http://ocw.mit.edu 20.453J / 2.771J / HST.958J Biomedical Fall 2008 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms. 2.771J 20.453J

More information

Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape

Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape Introduction Biomarkers and specialty labs are core to modern clinical trials.the broad and evergrowing

More information

Using semantic web technology to accelerate plant breeding.

Using semantic web technology to accelerate plant breeding. Using semantic web technology to accelerate plant breeding. Pierre-Yves Chibon 1,2,3, Benoît Carrères 1, Heleena de Weerd 1, Richard G. F. Visser 1,2,3, and Richard Finkers 1,3 1 Wageningen UR Plant Breeding,

More information

Exploration des données d essais cliniques en utilisant le standard CDISC

Exploration des données d essais cliniques en utilisant le standard CDISC Exploration des données d essais cliniques en utilisant le standard CDISC Florence Kussener French System Engineer Florence.Kussener@jmp.com SAS Institute AGENDA Outcomes of using CDISC standards Case

More information

Machine Learning in Pharmaceutical Research

Machine Learning in Pharmaceutical Research Machine Learning in Pharmaceutical Research Dr James Weatherall Global Director of Biomedical & Clinical Informatics AstraZeneca Research & Development October 2011 Overview Background: Pharmaceutical

More information

The use of electronic Health Records in Clinical Research - The value of CDISC Standards

The use of electronic Health Records in Clinical Research - The value of CDISC Standards The use of electronic Health Records in Clinical Research - The value of CDISC Standards FH-Prof. Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria Who is Jozef Aerts? CDISC volunteer

More information

Food and Drug Administration (FDA) 101

Food and Drug Administration (FDA) 101 Food and Drug Administration (FDA) 101 What is the Food and Drug Administration (FDA)? The FDA is an agency within the U.S. Department of Health and Human Services that is responsible for protecting the

More information

Putting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay

Putting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay Jon Roth, Vice President, Data Sciences & Biometrics Authorized Trainer for ADaM, CDISC Mark Vieder,

More information

PCORI Methodology Standards: Academic Curriculum Patient-Centered Outcomes Research Institute. All Rights Reserved.

PCORI Methodology Standards: Academic Curriculum Patient-Centered Outcomes Research Institute. All Rights Reserved. PCORI Methodology Standards: Academic Curriculum 2016 Patient-Centered Outcomes Research Institute. All Rights Reserved. Module 5: Architecture for Data Networks Category 7: Data Networks as Research-Facilitating

More information

Terminology Needs in Clinical Decision Support. Samson Tu Senior Research Scientist Center for Biomedical Informatics Research Stanford University

Terminology Needs in Clinical Decision Support. Samson Tu Senior Research Scientist Center for Biomedical Informatics Research Stanford University Terminology Needs in Clinical Decision Support Samson Tu Senior Research Scientist Center for Biomedical Informatics Research Stanford University 11th International Protégé Conference Workshop Amsterdam,

More information

Interlinked data and models using a semantic approach: example of the RECORD platform in the context of the ANAEE-France project

Interlinked data and models using a semantic approach: example of the RECORD platform in the context of the ANAEE-France project Interlinked data and models using a semantic approach: example of the RECORD platform in the context of the ANAEE-France project H.Raynal (U.MiAT, INRA, Toulouse), A.Chanzy (UMR EMMAH, INRA, Avignon),

More information

Clinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare

Clinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare Clinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare NIH HCS Collaboratory and PCORnet December 1, 2017 Stanley

More information

HD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington s disease

HD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington s disease HD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington s disease Critical Path Institute / CHDI Foundation Huntington s Disease Regulatory Science Consortium

More information

The 150+ Tomato Genome (re-)sequence Project; Lessons Learned and Potential

The 150+ Tomato Genome (re-)sequence Project; Lessons Learned and Potential The 150+ Tomato Genome (re-)sequence Project; Lessons Learned and Potential Applications Richard Finkers Researcher Plant Breeding, Wageningen UR Plant Breeding, P.O. Box 16, 6700 AA, Wageningen, The Netherlands,

More information

Project Data Sphere Data Sharing in Cancer Research. Joel Beetsch, PhD Faster Cures, November 4th, 2013

Project Data Sphere Data Sharing in Cancer Research. Joel Beetsch, PhD Faster Cures, November 4th, 2013 Project Data Sphere Data Sharing in Cancer Research Joel Beetsch, PhD Faster Cures, November 4th, 2013 Disclaimer The opinions expressed in this presentation are my own, and not that of either Celgene

More information

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities

More information

Implementation and Operation of CDISC ODM-based EDC by UMIN

Implementation and Operation of CDISC ODM-based EDC by UMIN Implementation and Operation of CDISC ODM-based EDC by UMIN Takahiro Kiuchi, M.D., Ph.D. UMIN Center, The University of Tokyo Hospital, Tokyo, Japan 1 Content 1. CDISC standards and academic research 2.

More information

JMP JMP Pro JMP Genomics JMP Clinical JMP Add-Ins

JMP JMP Pro JMP Genomics JMP Clinical JMP Add-Ins JMP FAMILY OF PRODUCTS: SOFTWARE FOR LIFE SCIENTISTS JMP JMP Pro JMP Genomics JMP Clinical JMP Add-Ins CLINICAL TRIAL DATA REVIEWS Randomized clinical trial remains the gold standard for evaluating efficacy

More information

SNOMED CT in the Age of Precision Medicine

SNOMED CT in the Age of Precision Medicine SNOMED CT in the Age of Precision Medicine Charles Gutteridge, Clinical Engagement Lead EMEA, SNOMED International @ gutteridgec HOW DO HUMANS ACT? 31414400 16064300 230063004 Dr Charles Gutteridge Clinical

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

Evolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network

Evolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network Evolving Regulatory Guidance on Submission of Standardized Data James R. Johnson, PhD RTP CDISC User Network 2014-06-11 Originally Presented at PhUSE Conference 2013 Brussels, Belgium (Paper Number: RG03)

More information

Making the most of existing evidence in the OHDSI evidence generation environment

Making the most of existing evidence in the OHDSI evidence generation environment Making the most of existing evidence in the OHDSI evidence generation environment An update from the Knowledge Base (Laertes) workgroup Richard D Boyce, Martijn Schuemie, Anthony Sena April 12 th, 2016

More information

LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017

LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017 LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017 Lauren Becnel, Ph.D. VP, Biomedical Informatics & Alliances, CDISC Asst Prof, Duncan Comprehensive Cancer Center,

More information

Application of Deep Learning to Drug Discovery

Application of Deep Learning to Drug Discovery Application of Deep Learning to Drug Discovery Hase T, Tsuji S, Shimokawa K, Tanaka H Tohoku Medical Megabank Organization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure

More information

Interoperability for clinical research Observational Health Data Sciences and Informatics (OHDSI)

Interoperability for clinical research Observational Health Data Sciences and Informatics (OHDSI) 9 ème École d'eté Méditerranéenne d'information en Santé Corte, France July 18, 2017 Interoperability for clinical research Observational Health Data Sciences and Informatics (OHDSI) Olivier Bodenreider

More information

Big Data & Clinical Informatics

Big Data & Clinical Informatics Big Data & Clinical Informatics Client Overview A leading clinical intelligence company that powers healthcare providers, life sciences and research organizations to make better-informed, more confident

More information

The INFRAFRONTIER Research Infrastructure Michael Hagn Helmholtz Zentrum München

The INFRAFRONTIER Research Infrastructure Michael Hagn Helmholtz Zentrum München The INFRAFRONTIER Research Infrastructure Michael Hagn Helmholtz Zentrum München High-quality resources and services for biomedical research European Research Infrastructure for the generation, systemic

More information

THE GETTY VOCABULARIES TECHNICAL SOLUTIONS OVERVIEW

THE GETTY VOCABULARIES TECHNICAL SOLUTIONS OVERVIEW AAT TGN ULAN CONA THE GETTY VOCABULARIES TECHNICAL SOLUTIONS OVERVIEW International Working Group Meetings Friday, September 5, 2014 Joan Cobb IT Specialists Project Manager Getty Information Technology

More information

Semantic Enrichment and the Information Manager

Semantic Enrichment and the Information Manager WHITEPAPER Semantic Enrichment and the Information Manager Turning Content into Insight It is more resource intensive to bring a drug to market than ever before: Pharmaceutical companies spend an average

More information

Rare Diseases: Challenges and Opportunities NIH Perspective

Rare Diseases: Challenges and Opportunities NIH Perspective Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes

More information

Application of Deep Learning to Drug Discovery

Application of Deep Learning to Drug Discovery Application of Deep Learning to Drug Discovery Hiroshi Tanaka Tohoku Medical Megabank Orga nization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure More than 1B

More information

CDISC Production Standards Status & Plans

CDISC Production Standards Status & Plans Bay Area User Network CDISC Production Standards Status & Plans Wayne R. Kubick Sr. Vice President, Lincoln Technologies CDISC Technical Director SDS Team Leader Agenda Topics The role and work of the

More information

ONTOLOGY BASED INFORMATION EXTRACTION FOR DISEASE INTELLIGENCE

ONTOLOGY BASED INFORMATION EXTRACTION FOR DISEASE INTELLIGENCE International Journal of Research in Computer Science eissn 2249-8265 Volume 2 Issue 6 (2012) pp. 7-19, A Unit of White Globe Publications doi: 10.7815/ijorcs.26.2012.051 ONTOLOGY BASED INFORMATION EXTRACTION

More information

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia

More information

Enhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use

Enhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use Enhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use Michael Waters, Ph.D. Michael.Waters@fda.hhs.gov Office of In Vitro

More information

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Indicative list Proposed topic /11 /11 /11 Identification and validation of innovative clinical endpoints for Osteoarthritis European genotype-phenotype

More information

Semantic Technology for Information Management. Gilbane Conference

Semantic Technology for Information Management. Gilbane Conference Semantic Technology for Information Management Gilbane Conference November 29, 2007 Discussion Agenda Case Study - A Global Pharma s R&D Information Challenge Enterprise Semantic Architecture and Strategies

More information

Deployment of SAS Programming Contract Staff: Pathway to Sinkhole or Best Strategy for Programming Division? Parag Shiralkar, Eliassen Group, NJ, USA

Deployment of SAS Programming Contract Staff: Pathway to Sinkhole or Best Strategy for Programming Division? Parag Shiralkar, Eliassen Group, NJ, USA PharmaSUG 2013 Paper MS04 Deployment of SAS Programming Contract Staff: Pathway to Sinkhole or Best Strategy for Programming Division? Parag Shiralkar, Eliassen Group, NJ, USA Abstract In pharmaceutical

More information

Applying SDTM and ADaM to the Construction of Datamarts in Support of Cross-indication Regulatory Requests

Applying SDTM and ADaM to the Construction of Datamarts in Support of Cross-indication Regulatory Requests Applying SDTM and ADaM to the Construction of Datamarts in Support of Cross-indication Regulatory Requests Data-what? This presentation will discuss some of the complexities involved when integrating study

More information

John Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment.

John Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment. 1. (15 pts) John Gurdon won the 2012 Nobel Prize in Physiology or Medicine for work he did in the 1960 s. What was the major developmental hypothesis he set out to test? What techniques did he development

More information

AEO: a realism-based biomedical ontology for the representation of adverse events

AEO: a realism-based biomedical ontology for the representation of adverse events AEO: a realism-based biomedical ontology for the representation of adverse events Yongqun He 1, Zuoshuang Xiang 1, Sirarat Sarntivijai 1, Luca Toldo 2, Werner Ceusters 3 1 University of Michigan Medical

More information

FDA Perspective on the Preclinical Development of Cancer Vaccines

FDA Perspective on the Preclinical Development of Cancer Vaccines FDA Perspective on the Preclinical Development of Cancer Vaccines Richard D. McFarland Ph.D., M.D. Medical Officer CBER/OCTGT/DCEPT mcfarlandr@cber.fda.gov Cancer Vaccine Clinical Trials Workshop Alexandria,

More information

Management in Pharmaceutical Industry

Management in Pharmaceutical Industry Master Program Management: Industrial Management Module: Chemistry for Drug Substances Management in Pharmaceutical Industry Prof. Tatsiana Savitskaya Assoc. Prof. Iryna Kimlenka Lectures 5,6 The Key Aspects:

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases

More information

Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration

Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration 1 2 Translational Informatics Overview Precision s suite of services is

More information

Chapter 1. Pharmaceutical Industry Overview

Chapter 1. Pharmaceutical Industry Overview Chapter 1 Pharmaceutical Industry Overview 1.1 Introduction 2 1.2 Regulations 2 1.2.1 Health Insurance Portability and Accountability Act 2 1.2.2 The Code of Federal Regulations 3 1.2.3 Guidance for Industry

More information

SEMANTIC DATA PLATFORM FOR HEALTHCARE. Dr. Philipp Daumke

SEMANTIC DATA PLATFORM FOR HEALTHCARE. Dr. Philipp Daumke SEMANTIC DATA PLATFORM FOR HEALTHCARE Dr. Philipp Daumke ABOUT AVERBIS Founded: 2007 Location: Team: Focus: Current Sectors: Freiburg, Germany Domain & IT-Experts Leverage structured & unstructured information

More information

Targeted Drug Discovery through Data Mining. Copyright 2000 SAS EMEA

Targeted Drug Discovery through Data Mining. Copyright 2000 SAS EMEA Targeted Drug Discovery through Data Mining John Brocklebank, PhD Development Director for Enterprise Miner Wayne Thompson, PhD Product Strategist Data Mining Introduction! This presentation will provide

More information

The Innovative Medicines Initiative Socio-economic impacts

The Innovative Medicines Initiative Socio-economic impacts The Innovative Medicines Initiative Socio-economic impacts Pierre Meulien, IMI Executive Director European Innovation Summit European Parliament 08.12.2015 Closed & open innovation Filing Approval HTA

More information

Engineering Genetic Circuits

Engineering Genetic Circuits Engineering Genetic Circuits I use the book and slides of Chris J. Myers Lecture 0: Preface Chris J. Myers (Lecture 0: Preface) Engineering Genetic Circuits 1 / 19 Samuel Florman Engineering is the art

More information

NCI Research Networks Model for Collaboration with Bioelectronics Round Table

NCI Research Networks Model for Collaboration with Bioelectronics Round Table NCI Research Networks Model for Collaboration with Bioelectronics Round Table Larry Clarke, Cancer Imaging Program DCDT, NCI Detail: NIBIB Guest Scientist: NIST 1 Bioelectronics Round Table Research Triangle

More information

New Frontiers in Personalized Medicine

New Frontiers in Personalized Medicine New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended

More information

SMEs in IMI2 Calls for Proposals

SMEs in IMI2 Calls for Proposals SMEs in IMI2 Calls for Proposals Why should an SME participate in an IMI project IMI projects are focused on translating excellent research into real world outcomes an opportunity for SMEs Unique collaborative

More information

CDISC Data Standards Validation

CDISC Data Standards Validation CDISC Data Standards Validation How can it be done? Peter Van Reusel Business Unit Director Business & Decision Life Sciences Tel +32 2 774 11 00 Fax +32 2 774 11 99 Mobile +32 476 54 59 17 peter.vanreusel@businessdecision.com

More information

Translational Medicine From Discovery to Health

Translational Medicine From Discovery to Health Translational Medicine From Discovery to Health Jamal A. Ibdah, MD, PhD Sr. Associate Dean & Director, MU Institute for Clinical and Translational Science Translational Medicine Translational Medicine

More information

Regulatory Challenges of Global Drug Development in Oncology. Jurij Petrin, M.D. Princeton, NJ

Regulatory Challenges of Global Drug Development in Oncology. Jurij Petrin, M.D. Princeton, NJ Regulatory Challenges of Global Drug Development in Oncology Jurij Petrin, M.D. Princeton, NJ Topics General global R&D issues Regulatory issues with global oncology drug development US FDA initiatives

More information

Question and Answer Guide Regarding Notification on Practical Operations of Electronic Study Data Submissions

Question and Answer Guide Regarding Notification on Practical Operations of Electronic Study Data Submissions Administrative Notice April 27, 2015 To: Prefectrual Health Department (Bureau) Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Question

More information

Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton

Future of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton Future of the Project BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton What were goals of BioMedBridges? GOAL 1: To provide computational data and service bridges between

More information

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date F o r a c l e a r e r m a r k e t p e r s p e c t i v e Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y Report

More information

Personalized Medicine

Personalized Medicine Personalized Medicine Dr. Pablo Mentzinis, Director Government Relations, SAP SE Courtesy by Dominik Bertram, Marc von der Linden, Péter Adorján, SAP June 2016 1. Traditional medicine vs. personalized

More information

Genomic Medicine in France

Genomic Medicine in France Genomic Medicine in France Catherine Nguyen, PhD Director ITMO GGB Genetic, Genomic & Bioinformatic Advancing Disease Modeling in Animal-Based research in Support of Precision Medecine: a Workshop ILAR

More information

The HLA Community s Success in Combining Clinical & Genomic Data

The HLA Community s Success in Combining Clinical & Genomic Data The HLA Community s Success in Combining Clinical & Genomic Data Elizabeth Trachtenberg MS, PhD, DABHI Director, Center for Applied Genomics HLA/Immunogenetics Laboratory Children s Hospital & Research

More information

Data & Materials Sharing Agreement. Collaboration for AIDS Vaccine Discovery. Clinical Trials Data Sharing Addendum & Related Information

Data & Materials Sharing Agreement. Collaboration for AIDS Vaccine Discovery. Clinical Trials Data Sharing Addendum & Related Information Data & Materials Sharing Agreement Collaboration for AIDS Vaccine Discovery Clinical Trials Data Sharing Addendum & Related Information I. Overview of this Document The primary purpose of this document

More information

Webinar IMI2 Call 14 Opportunities for SMEs

Webinar IMI2 Call 14 Opportunities for SMEs Webinar IMI2 Call 14 Opportunities for SMEs 19 March 2018 Agenda How to use GoToWebinar Catherine Brett, IMI Opportunities for SMEs Colm Carroll, IMI Questions & answers How to use GoToWebinar - audio

More information

Electronic Healthcare Record and Clinical Research in Cardiovascular Radiology. HL7 CDA and CDISC ODM Interoperability

Electronic Healthcare Record and Clinical Research in Cardiovascular Radiology. HL7 CDA and CDISC ODM Interoperability Electronic Healthcare Record and Clinical Research in Cardiovascular Radiology. HL7 CDA and CDISC ODM Interoperability A. El Fadly a, C. Daniel ab, C. Bousquet ab, T. Dart b, P-Y. Lastic c, P. Degoulet

More information

Translational Research

Translational Research Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic

More information

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution

More information

A journey into European factories of the future: The best Horizon 2020 projects are visiting Graz

A journey into European factories of the future: The best Horizon 2020 projects are visiting Graz Karl Hribernik BIBA Bremer Institut für Produktion und Logistik GmbH Horizon 2020 European Union Funding for Research & Innovation Agenda 1. FALCON Project Details 2. Consortium 3. Objectives & Approach

More information

Biological resources in the Plant Biology and Breeding division of INRA

Biological resources in the Plant Biology and Breeding division of INRA Plant Biology and Breeding Division Biological resources in the Plant Biology and Breeding division of INRA A-F Adam-Blondon Eurisco workshop, Angers, October 12th 2016 French National Institute for Research

More information

CDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care

CDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care CDISC International Interchange Program Embracing a Changing Landscape Standards to Connect Research and Patient Care B e t h e s d a N o r t h M a r r i o t t H o t e l a n d C o n f e r e n c e C e n

More information

Ontologies examples and applications

Ontologies examples and applications Web Science & Technologies University of Koblenz Landau, Germany Ontologies examples and applications 2 UMLS - Unified Medical Language System Framework consisting of several knowledge bases and according

More information

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December

More information

MICROARRAYS+SEQUENCING

MICROARRAYS+SEQUENCING MICROARRAYS+SEQUENCING The most efficient way to advance genomics research Down to a Science. www.affymetrix.com/downtoascience Affymetrix GeneChip Expression Technology Complementing your Next-Generation

More information

Innovations in Clinical

Innovations in Clinical Innovations in Clinical Accelerating Insights & Data-Driven Decisions Masha Hoffey Director, Clinical Analytics 15 September 2016 HUMAN HEALTH ENVIRONMENTAL HEALTH 2014 PerkinElmer Contents Introduction

More information

Integrating Pharmacogenomics into Decision Making

Integrating Pharmacogenomics into Decision Making Integrating Pharmacogenomics into Decision Making Munir Pirmohamed David Weatherall Chair of Medicine and NHS Chair of Pharmacogenetics Department of Molecular and Clinical Pharmacology Institute of Translational

More information

Ontology: A Vision for the Future and Its Realization. What Is An Ontology?

Ontology: A Vision for the Future and Its Realization. What Is An Ontology? Ontology: A Vision for the Future and Its Realization Mark A. Musen (Stanford University) Barry Smith (University at Buffalo) What Is An Ontology? The study of being A discipline co-opted by computer science

More information

Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA

Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA Eileen Navarro MD, FACP Medical Officer, OCS, OTS, CDER, FDA 1 www.fda.gov WHAT MEDICAL REVIEWERS CAN DO WITH STANDARDIZED DATA AND METADATA RECEIVED IN MODULE 5 Eileen Navarro, MD, FACP OCS/OTS/CDER/FDA

More information

Data Types in Bioinformatics

Data Types in Bioinformatics Data Types in Bioinformatics Patient diagnostics Karyotypes Fluorescent In Situ Hybridization Polymorphisms Microarrays, from pictures to interpretation Genetic sequence, from raw trace files to base-calls

More information

CDASH 2.0. Berlin Éanna Kiely CDISC Engineer

CDASH 2.0. Berlin Éanna Kiely CDISC Engineer CDASH 2.0 Berlin Éanna Kiely CDISC Engineer 2016-09-13 Agenda CDASH 1.1 & CDASHIG 2.0 CDASH Concepts TAUG Examples Current Regulatory Perspective on CDASH Questions 2 CDASH: CDISC End to End Clinical Data

More information

Gene expression connectivity mapping and its application to Cat-App

Gene expression connectivity mapping and its application to Cat-App Gene expression connectivity mapping and its application to Cat-App Shu-Dong Zhang Northern Ireland Centre for Stratified Medicine University of Ulster Outline TITLE OF THE PRESENTATION Gene expression

More information

IN the inaugural issue of the IEEE Transactions on Services Computing (TSC), I used SOA, service-oriented consulting

IN the inaugural issue of the IEEE Transactions on Services Computing (TSC), I used SOA, service-oriented consulting IEEE TRANSACTIONS ON SERVICES COMPUTING, VOL. 1, NO. 2, APRIL-JUNE 2008 62 EIC Editorial: Introduction to the Body of Knowledge Areas of Services Computing Liang-Jie (LJ) Zhang, Senior Member, IEEE IN

More information

Development Stage of Therapeutic Vaccines: The Regulator s View

Development Stage of Therapeutic Vaccines: The Regulator s View Development Stage of Therapeutic Vaccines: The Regulator s View Thomas Hinz Head, Section Therapeutic Vaccines Paul Ehrlich Institute, Germany thomas.hinz@pei.de 1 DISCLAIMER This is the personal views

More information

Dana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse

Dana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse Dana-Farber Cancer Institute Speeds Medical Research with Advanced Data Warehouse Dana-Farber Cancer Institute Boston, MA www.dana-farber.org Industry: Healthcare Annual Revenue: US$665.7 million Employees:

More information